US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,327.58

-9.1315-0.68%

Number of Gainers:5

Number of Losers:15

Number of Flat:- -

PE:- -

High:1,343.21

Open:1,342.69

Low:1,326.57

Close:1,336.71

Loading ...

BRIEF-Gilead To Invest $32 Bln In U.S. Manufacturing And R&D Through 2030

Gilead to Invest $32 Billion in U.S. Manufacturing and R&D Through 2030 and Create More Than 3,000 Direct and Indirect Jobs by 2028

THOMSON REUTERS

AstraZeneca Says Enhertu Followed by THP Improved Pathologic Complete Response Rate in Breast Cancer Study

MT Newswires Live

AstraZeneca (AZN) Gets a Buy from J.P. Morgan

Press Release: Notice of Nominees for Directors

FACTBOX-European companies cut jobs in response to slowing economy

Abbott India Says Swati Dalal Resigns As Managing Director

BUZZ- Sanofi drops as FDA names agency critic as top vaccine official

Gilead Sciences Announces Promising Phase 3 Results: 90% of HDV Patients Maintain Undetectable Virus Levels After Bulevirtide Treatment

Analysts Conflicted on These Healthcare Names: Immutep Ltd (OtherPRRUF), Organon (OGN) and BioNTech SE (BNTX)

Bitwise Seeks SEC Approval for NEAR ETF with S-1 Filing

BioNTech SE (BNTX) Gets a Buy from Evercore ISI

Why BioNTech Stock Got Trounced on Tuesday

Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review

MT Newswires Live

EXCLUSIVE-Kennedy aide and vaccine critic questions recent expert recommendations

BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official

Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator -- Barrons.com

Moderna Falls 12%, Pfizer Falls 3.3% and Novavax Falls 6.3%

THOMSON REUTERS

BUZZ-Drugmakers fall as Trump signals announcement on medicine costs

Global Business Travel reports Q1 EPS 16c, consensus 17c

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1327.5806,"timestamp":1746820799999,"preClose":1336.712,"halted":0,"volume":113582454,"delay":0,"changeRate":-0.006831,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-9.13147,"latestTime":"05-09 16:00:00 EDT","open":1342.69,"high":1343.2052,"low":1326.5701,"amount":4653162209.902576,"amplitude":0.012445,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.565313,"peRate":21.186942,"turnoverRate":0.007317,"increases":5,"decrements":15,"flats":0,"marketCap":1093969830401.5,"floatMarketCap":1075897192963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1343.2052,"amplitude":0.012445,"preClose":1336.712,"low":1326.5701,"pbRate":"3.565313","latestPrice":1327.5806,"volume":113582454,"delay":0,"open":1342.69,"prevYearClose":1274.8187,"prevWeekClose":1375.2667,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1375.2667,"twentyDayClose":1281.7616,"sixtyDayClose":1380.7908,"secType":"PLATE","market":"US","turnoverRate":0.007317,"peRate":21.186942,"marketCap":1093969830401.5,"floatMarketCap":1075897192963,"timestamp":1746820799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533795068","title":"BRIEF-Gilead To Invest $32 Bln In U.S. Manufacturing And R&D Through 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2533795068","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533795068?lang=en_us&edition=fundamental","pubTime":"2025-05-08 02:43","pubTimestamp":1746643417,"startTime":"0","endTime":"0","summary":"BRIEF-Gilead To Invest $32 Bln In U.S. Manufacturing And R&D Through 2030May 7  - Gilead Sciences Inc GILD.O:GILEAD TO INVEST $32 BILLION IN U.S. MANUFACTURING AND RESEARCH AND DEVELOPMENT THROUGH 2030 AND CREATE MORE THAN 3,000 DIRECT AND INDIRECT JOBS BY 2028 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF39F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1571399168.USD","LU1066051498.USD","LU2468319806.SGD","BK4566","LU1585245621.USD","BK4532","GILD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","IE00B19Z3581.USD","BK4585","BK4583","BK4139","BK4588","IE00BKVL7J92.USD","BK4578","LU0234570918.USD","BK4568","LU1778281490.HKD","LU1674673691.USD","LU2089984988.USD","LU2087621335.USD","LU0109394709.USD","IE00B3T34201.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU1839511570.USD","LU1674673428.USD","LU1430594728.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2533508749","title":"Gilead to Invest $32 Billion in U.S. Manufacturing and R&D Through 2030 and Create More Than 3,000 Direct and Indirect Jobs by 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2533508749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533508749?lang=en_us&edition=fundamental","pubTime":"2025-05-08 02:38","pubTimestamp":1746643132,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF39F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","BK4566","IE00B3T34201.USD","LU2087621335.USD","LU0289739699.SGD","BK4568","IE00B7SZLL34.SGD","BK4532","BK4578","BK4588","LU0320765992.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4585","LU0234570918.USD","BK4583","IE00BSNM7G36.USD","LU1430594728.SGD","IE0002270589.USD","LU1839511570.USD","LU1585245621.USD","LU2468319806.SGD","LU0889565916.HKD","LU1571399168.USD","LU1674673428.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU2089984988.USD","GILD","BK4139","LU0058720904.USD","IE00B19Z3581.USD","LU1066053197.SGD","LU1066051498.USD","LU1778281490.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2533375879","title":"AstraZeneca Says Enhertu Followed by THP Improved Pathologic Complete Response Rate in Breast Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2533375879","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533375879?lang=en_us&edition=fundamental","pubTime":"2025-05-07 22:48","pubTimestamp":1746629324,"startTime":"0","endTime":"0","summary":"AstraZeneca  said Wednesday Enhertu followed by paclitaxel, trastuzumab and pertuzumab or THP improved the pathologic complete response rate compared with standard of care in a phase 3 breast cancer study.Pathologic complete response, or the absence of invasive cancer cells in the removed breast tissue and lymph nodes after treatment, is the primary endpoint of the study, the company said.Achieving that response in early-stage HER2-positive breast cancer is linked to enhanced long-term outcomes, the company added.The secondary endpoint of event-free survival wasn't mature at the time of analysis, but data showed an early positive trend for Enhertu followed by THP as well, the company said.The company and Daiichi Sankyo agreed to jointly develop and commercialize Enhertu in 2019, AstraZeneca said.Price: 70.12, Change: -0.14, Percent Change: -0.20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","BK4007","LU2456880835.USD","LU2236285917.USD","LU0889565916.HKD","LU2462157665.USD","BK4585","LU0320765992.SGD","BK4588","LU2417539215.USD","BK4568","LU1829250122.USD","AZN"],"gpt_icon":0},{"id":"2533982036","title":"AstraZeneca (AZN) Gets a Buy from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2533982036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533982036?lang=en_us&edition=fundamental","pubTime":"2025-05-07 20:20","pubTimestamp":1746620425,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst James Gordon maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £140.00. According ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106261372.USD","LU0106831901.USD","LU0795875086.SGD","LU2236285917.USD","BK4534","LU2462157665.USD","LU0320765646.SGD","LU0158827948.USD","LU2357305700.SGD","LU2028103732.USD","LU2133065610.SGD","LU2417539215.USD","BK4504","LU1074936037.SGD","LU2111349929.HKD","LU2271345857.HKD","IE00BKVL7J92.USD","LU0912757837.SGD","LU2089284900.SGD","LU1720051017.SGD","LU0971096721.USD","LU1829250122.USD","LU1989772840.SGD","LU1548497426.USD","LU0225283273.USD","BK4516","AZN","LU0267386448.USD","LU1989772923.USD","LU1363072403.SGD","BK4007","BK4568","LU1732800096.USD","LU1162221912.USD","LU0314104364.USD","LU2089283258.USD","LU0889565916.HKD","LU0006306889.USD","LU2456880835.USD","LU1720051108.HKD","LU0158827781.USD","LU0795875169.SGD","LU2347655156.SGD","LU1732799900.SGD","LU0109394709.USD","LU0098860793.USD","BK4127","LU1668664300.SGD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2533907609","title":"Press Release: Notice of Nominees for Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2533907609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533907609?lang=en_us&edition=fundamental","pubTime":"2025-05-07 18:00","pubTimestamp":1746612000,"startTime":"0","endTime":"0","summary":"TOKYO, May 7, 2025 /PRNewswire/ -- Astellas Pharma Inc.  today announced that during a meeting of its Board of Directors held today, it decided a change in Directors as outlined below. The appointment of Andreas Busch and Mark Enyedy as new candidates to be proposed at the 20th Term Annual Shareholders Meeting scheduled for June 19, 2025, represents a significant move in the company's continuous evolution, aimed at enhancing the diverse composition of our Board of Directors. Their extensive experience and insight into the global pharmaceutical industry will further strengthen the board's supervisory function and effectiveness. This decision reflects the voices from stakeholders,  including shareholders. The change is subject to approval at the 20th Term Annual Shareholders Meeting and a subsequent decision at the Board of Directors meeting scheduled for the same day.Kenji Yasukawa       Reelection    Representative Director, Chairman of the. Naoki Okamura        Reelection    Represent","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4139","ALPMY","BK4585","BK4007","BK4535","BK4588","BK4568","BNTX","BK4551"],"gpt_icon":0},{"id":"2533603632","title":"FACTBOX-European companies cut jobs in response to slowing economy","url":"https://stock-news.laohu8.com/highlight/detail?id=2533603632","media":"Reuters","labels":["economic","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533603632?lang=en_us&edition=fundamental","pubTime":"2025-05-07 17:47","pubTimestamp":1746611224,"startTime":"0","endTime":"0","summary":"FACTBOX-European companies cut jobs in response to slowing economyAdds Volvo Cars, Prosiebensat.1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL1N3RF0EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","BK4588","BK4585","BK4535","BNTX","BK4548","BK4551"],"gpt_icon":0},{"id":"2533038946","title":"Abbott India Says Swati Dalal Resigns As Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2533038946","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533038946?lang=en_us&edition=fundamental","pubTime":"2025-05-07 17:43","pubTimestamp":1746610982,"startTime":"0","endTime":"0","summary":"May 7 (Reuters) - Abbott India Ltd ::*SWATI DALAL RESIGNS AS MANAGING DIRECTOR*KARTIK RAJENDRAN APPOINTED AS MANAGING DIRECTOR  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-MAY-202508:40:24.017 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nRSDwFZ4s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","ABT","LU0234572021.USD","LU0170899867.USD","LU1057294990.SGD","BK4581","SG9999004303.SGD","SG9999002224.SGD","LU2237957902.USD","IE00BFTCPJ56.SGD","LU0122379950.USD","LU2237957811.SGD","BK4568","LU1721429741.USD","LU2112291526.USD","LU1691799644.USD","LU0868494617.USD","LU1023059063.AUD","LU1989763427.SGD","IE0009355771.USD","BK4504","SG9999002232.USD","BK4585","LU2133065610.SGD","BK4592","BK4082","LU1721429402.USD","BK4566","IE00BJJMRZ35.SGD","LU1989763690.USD","LU1914381329.SGD","IE00B2B36J28.USD","SGXZ23171101.USD","LU0266013472.USD","IE00BJT1NW94.SGD","BK4533","IE00B4R5TH58.HKD","LU2089984988.USD","LU2468319806.SGD","BK4588","IE0002141913.USD"],"gpt_icon":0},{"id":"2533679800","title":"BUZZ- Sanofi drops as FDA names agency critic as top vaccine official","url":"https://stock-news.laohu8.com/highlight/detail?id=2533679800","media":"Reuters","labels":["executive","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533679800?lang=en_us&edition=fundamental","pubTime":"2025-05-07 16:40","pubTimestamp":1746607208,"startTime":"0","endTime":"0","summary":"BUZZ- Sanofi drops as FDA names agency critic as top vaccine official** Shares in Sanofi SASY.PA drop around 3% as U.S. FDA appointed on Tuesday the agency critic Vinay Prasad as top vaccine official*","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL8N3RF0US:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4548","BK4588","BK4568","BK4532","BK4551","BK4501","BK4139","BK4585","BK4533"],"gpt_icon":1},{"id":"2533621790","title":"Gilead Sciences Announces Promising Phase 3 Results: 90% of HDV Patients Maintain Undetectable Virus Levels After Bulevirtide Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2533621790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533621790?lang=en_us&edition=fundamental","pubTime":"2025-05-07 14:30","pubTimestamp":1746599457,"startTime":"0","endTime":"0","summary":"Gilead Sciences Announces Promising Phase 3 Results: 90% of HDV Patients Maintain Undetectable Virus Levels After Bulevirtide Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via Business Wire  on May 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nNDLS5kXk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU2087621335.USD","IE00B7SZLL34.SGD","LU0058720904.USD","LU2089984988.USD","BK4139","IE00B19Z3B42.SGD","BK4550","BK4588","IE00BZ1G4Q59.USD","BK4578","GILD","LU0320765992.SGD","LU1585245621.USD","BK4585","BK4568","BK4583","LU0234570918.USD","LU1066053197.SGD","LU1430594728.SGD","LU1674673428.USD","LU1066051498.USD","IE00BKVL7J92.USD","LU0109394709.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1839511570.USD","BK4532","BK4566","LU1778281490.HKD","LU0289739699.SGD","LU1571399168.USD","IE00B19Z3581.USD","LU2468319806.SGD","LU0889565916.HKD","IE0002270589.USD"],"gpt_icon":0},{"id":"2533218626","title":"Analysts Conflicted on These Healthcare Names: Immutep Ltd (OtherPRRUF), Organon (OGN) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533218626","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533218626?lang=en_us&edition=fundamental","pubTime":"2025-05-07 14:20","pubTimestamp":1746598816,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Immutep Ltd (PRRUF – Research Report), Organon (OG...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-immutep-ltd-otherprruf-organon-ogn-and-biontech-se-bntx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-immutep-ltd-otherprruf-organon-ogn-and-biontech-se-bntx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4137","BK4588","LU2065171402.SGD","OGN","HCSG","BK4007","BK4568","BNTX","BK4535","BK4551","LU2065170008.USD","BK4559","BK4139","LU2065169927.USD","BK4585","LU2065171311.SGD"],"gpt_icon":0},{"id":"2533620378","title":"Bitwise Seeks SEC Approval for NEAR ETF with S-1 Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2533620378","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533620378?lang=en_us&edition=fundamental","pubTime":"2025-05-07 13:19","pubTimestamp":1746595189,"startTime":"0","endTime":"0","summary":"Bitwise Asset Management submits Form S-1 to the SEC for a NEAR-based exchange-traded fund , marking a key step in its launch.The ETF will track the value of NEAR, the native token of the NEAR Protocol, with Coinbase Custody Trust managing the fund’s NEAR holdings.Bitwise Asset Management has formally submitted a Form S-1 registration statement to the US Securities and Exchange Commission  to launch the Bitwise NEAR exchange-traded fund .The filing follows Bitwise’s earlier move on April 24, 2025, when the firm registered a trust entity for the Bitwise NEAR ETF in Delaware. The S-1 marks the natural next step in the process.NEAR Joins the Altcoin ETF Race With Bitwise Filing. The proposed ETF aims to track the value of NEAR, the native token of the NEAR Protocol. It is a layer-1 blockchain focused on scalability and decentralized applications.This pattern of delays aligns with the SEC’s cautious approach to crypto ETFs beyond Bitcoin and Ethereum, despite a more favorable regulatory cl","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2023/01/BIC_NEAR_Protocol_bullish-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2023/01/BIC_NEAR_Protocol_bullish-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/bitwise-near-etf-filing-sec/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4594","SOL","FDN","APT","BTC","ETH","NEAR","APT.USD.HKCC","BK4568","LDO.USD.HKCC","BK4550","QETH","BTC.USD.HKCC","FETH","ETH.USD.HKCC","SOL.USD.HKCC","APT.USD.CC","BK4585","BK4086","BK4519","EZET","BK4129","ETHV","BK4588","BTC.USD.CC","CETH","BK4601","ETH.USD.CC"],"gpt_icon":1},{"id":"2533402636","title":"BioNTech SE (BNTX) Gets a Buy from Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2533402636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533402636?lang=en_us&edition=fundamental","pubTime":"2025-05-07 13:07","pubTimestamp":1746594458,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Cory Kasimov from Evercore ISI reiterated a Buy rating on BioNTech SE (BNTX – Research Report), with a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biontech-se-bntx-gets-a-buy-from-evercore-isi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biontech-se-bntx-gets-a-buy-from-evercore-isi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4551","BK4568","BK4588","BK4139","BNTX","BK4535","BK4585"],"gpt_icon":0},{"id":"2533696618","title":"Why BioNTech Stock Got Trounced on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2533696618","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533696618?lang=en_us&edition=fundamental","pubTime":"2025-05-07 06:15","pubTimestamp":1746569700,"startTime":"0","endTime":"0","summary":"A new federal government appointment had investors worried about vaccine makers.This was compounded by an analyst's price target cut for the German biotech.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/06/why-biontech-stock-got-trounced-on-tuesday/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["HHS","BK4568","BNTX","BK4009","BK4585","BK4588","BK4139","BK4535","BK4548","BK4551"],"gpt_icon":0},{"id":"2533664717","title":"Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2533664717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533664717?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:13","pubTimestamp":1746562414,"startTime":"0","endTime":"0","summary":"A recommendation to expand the indication for respiratory syncytial virus vaccines developed by Pfizer (PFE) and GSK (GSK) is being reviewed by a top aide to US Health Secretary Robert Kennedy, Reuter","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE000M9KFDE8.USD","BK4533","LU1829250122.USD","SG9999003800.SGD","BK4592","BK4532","BK4581","LU0225771236.USD","BK4599","LU1057294990.SGD","PFE","IE00BLSP4452.SGD","LU1894683348.USD","SG9999002232.USD","LU0234572021.USD","BK4568","BK7095","IE00BLSP4239.USD","LU1066051498.USD","LU0321505439.SGD","BK4007","SGXZ57979304.SGD","LU0321505868.SGD","LU0058720904.USD","IE0002270589.USD","LU1883839398.USD","GSK.UK","LU0868494617.USD","SG9999002224.SGD","LU0306807586.USD","BK4588","LU1894683264.USD","LU1066053197.SGD","PFE.AU","LU0170899867.USD","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD","LU0122379950.USD","BK4534","LU0456855351.SGD","GSK","LU0306806265.USD","SG9999001176.SGD","LU0985481810.HKD","BK4585","IE00B19Z3B42.SGD","SG9999001176.USD","IE00BBT3K403.USD","BK4550"],"gpt_icon":1},{"id":"2533543669","title":"EXCLUSIVE-Kennedy aide and vaccine critic questions recent expert recommendations","url":"https://stock-news.laohu8.com/highlight/detail?id=2533543669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533543669?lang=en_us&edition=fundamental","pubTime":"2025-05-07 03:30","pubTimestamp":1746559824,"startTime":"0","endTime":"0","summary":"EXCLUSIVE-Kennedy aide and vaccine critic questions recent expert recommendationsKennedy aide Archer criticized vaccines on social media Archer seeks more data on RSV vaccine efficacyKennedy reviewing","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL6N3RE0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0234572021.USD","IE00BBT3K403.USD","BK4581","LU1035777561.USD","LU1023059063.AUD","LU1228905037.USD","LU0225771236.USD","LU1645745479.HKD","LU1098665638.USD","IE00BWDBJ516.SGD","LU1883839398.USD","SG9999011175.SGD","LU0575583348.USD","LU1894683348.USD","IE0034235071.USD","LU1400636491.USD","LU0211331839.USD","IE00B19Z3B42.SGD","BK4585","LU0545562505.USD","LU0122379950.USD","SG9999013999.USD","LU0170899867.USD","LU1066051498.USD","GSK.UK","IE00BLSP4452.SGD","BK5011","LU1481600234.SGD","BK4533","LU1057294990.SGD","SG9999001176.USD","BK4599","LU0321505868.SGD","LU1487256676.USD","IE00BQJZX424.USD","LU0971552830.HKD","LU1670756490.USD","SGXZ57979304.SGD","LU1066053197.SGD","PFE","LU0109981661.USD","SG9999003800.SGD","BK4568","BK4592","IE00B19Z3581.USD","IE00BLSP4239.USD","LU1202635105.USD","BK4588","LU1046248800.SGD"],"gpt_icon":1},{"id":"2533631656","title":"BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official","url":"https://stock-news.laohu8.com/highlight/detail?id=2533631656","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533631656?lang=en_us&edition=fundamental","pubTime":"2025-05-07 02:20","pubTimestamp":1746555653,"startTime":"0","endTime":"0","summary":"BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official** Shares of vaccine maker Moderna MRNA.O and gene therapy developers fall between 12% and 22% after the U.S. FDA named Vinay Prasad as the director of its Center for Biologics Evaluation and Research ** Prasad was a fierce critic of COVID-19 vaccine and mask mandates** As the director of CBER, Prasad will oversee the regulation of vaccines and gene therapies** Shares of Moderna down 12.4%, Novavax NVAX.O down 5.2%, while Pfizer PFE.N, previously down after an announcement on medicine costs, extends losses to 3%** Shares of gene therapy developers such as Sarepta Therapeutics SRPT.O fall 21.5%, Taysha Gene Therapies TSHA.O fall 20.7%, Capricor Therapeutics CAPR.O down 20.3%** U.S.-listed shares of CRISPR Therapeutics CRSP.BN down 9.6%, Solid Biosciences SLDB.O down 15.3%, ** MRNA down 41.3% and SRPT down 61.1% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4N3RE1VN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","BK4534","BK4139","BK4548","IE0002270589.USD","IE00BFTCPJ56.SGD","IE00BLSP4452.SGD","LU1066053197.SGD","BK4501","IE00BJJMRZ35.SGD","CAPR","IE00BJT1NW94.SGD","LU0225771236.USD","LU1057294990.SGD","BK4532","SRPT","LU0868494617.USD","LU0058720904.USD","LU1066051498.USD","BK4585","SG9999003800.SGD","MRNA","IE000M9KFDE8.USD","LU1883839398.USD","SG9999013999.USD","NVAX","SG9999002232.USD","IE0002141913.USD","LU0985481810.HKD","BK4599","LU0306806265.USD","IE00B2B36J28.USD","LU0122379950.USD","LU0289739699.SGD","LU0456855351.SGD","BK4551","IE0009355771.USD","LU1894683264.USD","SG9999001176.SGD","BK4533","SGXZ57979304.SGD","BK4547","BK4568","LU1023059063.AUD","SLDB","SG9999001176.USD","SG9999002224.SGD","BK4581","SG9999011175.SGD"],"gpt_icon":1},{"id":"2533663892","title":"Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2533663892","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533663892?lang=en_us&edition=fundamental","pubTime":"2025-05-07 02:04","pubTimestamp":1746554640,"startTime":"0","endTime":"0","summary":"Biotech and pharmaceutical stocks were sliding Tuesday afternoon as the Food and Drug Administration named Dr. Vinay Prasad, a critic of FDA policy and the U.S. Covid-19 response, as its top vaccine regulator.Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA's Center for Biologics Evaluation and Research in March, writing in his resignation letter that Robert F. Kennedy Jr., the secretary of Health and Human Services, \"wishes subservient confirmation of his misinformation and lies.\" Marks was perhaps the best-known career official within the agency.Novavax, another Covid-19 vaccine maker, was down 6.7%.Big pharma stocks with significant vaccine businesses were falling as well. American depositary receipt of GSK, which was roughly flat on the day as of 12:30 p.m., was down 1.7% by 1:30 p.m. Merck, another large vaccine maker, was down 4.6%, while Pfizer fell 3.3.%. This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published inde","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4007","BK4588","BK4139","BK4548","GSK.UK","BK4551","BK4533","BK4585","BK4501","BK4532","BK4534","BK4568","NVAX","LU1829250122.USD","GSK"],"gpt_icon":1},{"id":"2533668912","title":"Moderna Falls 12%, Pfizer Falls 3.3% and Novavax Falls 6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533668912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533668912?lang=en_us&edition=fundamental","pubTime":"2025-05-07 01:50","pubTimestamp":1746553819,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nFWN3RE2HJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999003800.SGD","SG9999001176.SGD","LU0225771236.USD","LU0058720904.USD","LU1023059063.AUD","BK4533","LU0985481810.HKD","PFE","SG9999002232.USD","BK4139","SG9999002224.SGD","BK4550","IE00B19Z3B42.SGD","BK4007","BK4548","BK4588","LU0122379950.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","MRNA","BK4585","BK4592","BK4568","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4547","IE00BLSP4239.USD","SGXZ57979304.SGD","NVAX","BK4532","LU0868494617.USD","LU1883839398.USD","LU1894683264.USD","IE000M9KFDE8.USD","BK4581","LU0456855351.SGD","BK4599","SG9999011175.SGD","LU0170899867.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU1057294990.SGD","BK4501","IE0002270589.USD","LU1894683348.USD"],"gpt_icon":0},{"id":"2533656919","title":"BUZZ-Drugmakers fall as Trump signals announcement on medicine costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2533656919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533656919?lang=en_us&edition=fundamental","pubTime":"2025-05-06 23:21","pubTimestamp":1746544891,"startTime":"0","endTime":"0","summary":"BUZZ-Drugmakers fall as Trump signals announcement on medicine costs** Shares of U.S drugmakers fall after President Trump signaled he would make an announcement next week on the cost of medicines** Shares of Eli Lilly LLY.N and Abbvie ABBV.N fall 3% each, Merck MRK.N down 2.5%, Gilead GILD.O slip 2.4%, Amgen AMGN.O down 2.2%, Pfizer PFE.N fall 1.7%** The S&P 500 healthcare sector .SPXHC falls 1.5%** Trump said to reporters gathered at the White House the U.S. was being ripped off on medicine costs when compared to the rest of the world** He also said that he plans to announce pharmaceutical tariffs over the next two weeks** Trump's recent comments imply that pharma-specific tariff proposals are coming, but may not be as bad as expected, Jefferies says ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4N3RE1OX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU1496350502.SGD","LU0208291251.USD","IE000M9KFDE8.USD","LU2129689605.HKD","BK4532","SG9999014914.USD","LU1868837136.USD","LU0354030511.USD","SG9999015978.USD","LU0985481810.HKD","SG9999011175.SGD","LU1267930730.SGD","LU2361044949.HKD","LU0265550946.USD","LU1934455194.USD","IE00B19Z3581.USD","LU1941712264.USD","GILD","IE00BLSP4452.SGD","LU1732800096.USD","BK4516","LU1814569148.SGD","BK4559","MRK","LU0471298777.SGD","SGXZ81514606.USD","LU0889565916.HKD","LU1093756168.USD","PFE","LU0545039389.USD","LU0097036916.USD","LU1035775433.USD","LU2237443895.HKD","IE00BDGV0183.EUR","LU2264538146.SGD","LU1366192091.USD","AMGN","BK4568","LLY","LU1894683264.USD","BK4581","BK4592","IE00B3PB1722.GBP","LU1623119135.USD","LU0823416689.USD","LU0029864427.USD","LU0985320562.USD","ABBV","LU1983299246.USD"],"gpt_icon":1},{"id":"2533968729","title":"Global Business Travel reports Q1 EPS 16c, consensus 17c","url":"https://stock-news.laohu8.com/highlight/detail?id=2533968729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533968729?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532859,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $621M, consensus $633.54M. Reports Q1 total transaction value $8.35B. Paul Abbott, Amex GBT’s Chief Executive Officer, stated: “...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/global-business-travel-reports-q1-eps-16c-consensus-17c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/global-business-travel-reports-q1-eps-16c-consensus-17c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237957811.SGD","LU2237957902.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1989763427.SGD","IE00B4R5TH58.HKD","LU0266013472.USD","LU1721429402.USD","IE0009355771.USD","LU0122379950.USD","LU2133065610.SGD","BK4581","BK4585","LU1914381329.SGD","LU0234572021.USD","LU2468319806.SGD","SG9999002232.USD","SG9999004303.SGD","LU1989763690.USD","IE00BJT1NW94.SGD","BK4588","BK4568","LU1061106388.HKD","BK4592","ABT","BK4566","IE0002141913.USD","LU1721429741.USD","LU2112291526.USD","SGXZ23171101.USD","BK4082","LU1691799644.USD","SG9999002224.SGD","LU0868494617.USD","LU0170899867.USD","BK4504","LU1057294990.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4533","LU2089984988.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":4,"totalSize":328,"code":"91000000","status":"200"}]}}